Literature DB >> 1721015

Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release.

C Ferran1, M Dy, K Sheehan, S Merite, R Schreiber, P Landais, G Grau, J Bluestone, J F Bach, L Chatenoud.   

Abstract

Triggering of the CD3 molecule by in vivo injection of the hamster anti-murine CD3 monoclonal antibody 145-2C11 in adult BALB/c mice leads to massive although transient T cell activation. High levels of tumour necrosis factor (TNF), interferon-gamma (IFN-gamma), IL-2, IL-3 and IL-6 are released into the circulation 1 to 8 h after a single 10 micrograms 145-2C11 i.v. injection. This release induces an impressive self-limited physical reaction associating hypothermia, hypomotility (as assessed by actimetry), diarrhoea, piloerection and even death when high doses (a single dose of greater than 100 micrograms/mouse injection) are administered. In vivo injection of 145-2C11 to other selected mouse strains, namely NZW, CBA/J and C3H/HeJ, induced both different cytokine release patterns and sickness. 145-2C11 induced significant release of TNF and IL-2 in all four strains. At variance, IFN-gamma was only detected in BALB/c mice sera which, in terms of physical reaction (hypothermia and hypomotility) were the most affected. Higher and long-lasting circulating IL-3/GM-CSF levels were present in CBA/J sera, correlating with a later recovery. These results underline heterogeneity in the in vivo cell activation pattern among different mouse strains, when triggering T lymphocytes via the CD3/Ti molecule as compared to exclusive targeting of monocyte/macrophages by means of lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1721015      PMCID: PMC1554204          DOI: 10.1111/j.1365-2249.1991.tb02966.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.

Authors:  R Hirsch; J A Bluestone; C V Bare; R E Gress
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  The regulation of gamma-interferon production by interleukins 1 and 2.

Authors:  A D Croll; A G Morris
Journal:  Cell Immunol       Date:  1986-10-01       Impact factor: 4.868

3.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

4.  Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors.

Authors:  J E Talmadge; O Bowersox; H Tribble; S H Lee; H M Shepard; D Liggitt
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

5.  Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.

Authors:  B B Aggarwal; T E Eessalu; P E Hass
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

6.  Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids.

Authors:  C Ferran; M Dy; S Merite; K Sheehan; R Schreiber; F Leboulenger; P Landais; J Bluestone; J F Bach; L Chatenoud
Journal:  Transplantation       Date:  1990-10       Impact factor: 4.939

7.  Cellular mechanism of endotoxin unresponsiveness in C3H/HeJ mice.

Authors:  L M Glode; I Scher; B Osborne; D L Rosenstreich
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

8.  Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes.

Authors:  J M Debets; C J Van der Linden; I E Dieteren; J F Leeuwenberg; W A Buurman
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

9.  Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses.

Authors:  R Hirsch; M Eckhaus; H Auchincloss; D H Sachs; J A Bluestone
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

10.  Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody.

Authors:  S S Sung; J M Bjorndahl; C Y Wang; H T Kao; S M Fu
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Myosin light chain kinase: pulling the strings of epithelial tight junction function.

Authors:  Kevin E Cunningham; Jerrold R Turner
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

2.  Induction of diverse T cell memory through antibody-mediated activation in mice.

Authors:  Matthew D Taylor; Mariana R Brewer; Clifford S Deutschman
Journal:  Eur J Immunol       Date:  2020-07-29       Impact factor: 5.532

3.  PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.

Authors:  Paul M Schroder; Mithun Khattar; Caitlin E Baum; Yoshihiro Miyahara; Wenhao Chen; Rohit Vyas; Shravan Muralidharan; Beata Mierzejewska; Stanislaw M Stepkowski
Journal:  Diabetologia       Date:  2015-03-21       Impact factor: 10.122

4.  Effector and Activated T Cells Induce Preterm Labor and Birth That Is Prevented by Treatment with Progesterone.

Authors:  Marcia Arenas-Hernandez; Roberto Romero; Yi Xu; Bogdan Panaitescu; Valeria Garcia-Flores; Derek Miller; Hyunyoung Ahn; Bogdan Done; Sonia S Hassan; Chaur-Dong Hsu; Adi L Tarca; Carmen Sanchez-Torres; Nardhy Gomez-Lopez
Journal:  J Immunol       Date:  2019-03-27       Impact factor: 5.422

5.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Authors:  C Ferran; F Dautry; S Mérite; K Sheehan; R Schreiber; G Grau; J F Bach; L Chatenoud
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection.

Authors:  S D Bergese; E H Huang; R P Pelletier; M B Widmer; R M Ferguson; C G Orosz
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

7.  Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.

Authors:  L Chatenoud; E Thervet; J Primo; J F Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

8.  Retinoic acid inhibits in vivo interleukin-2 gene expression and T-cell activation in mice.

Authors:  Aase Ertesvag; Liv M I Austenaa; Harald Carlsen; Rune Blomhoff; Heidi Kiil Blomhoff
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

9.  Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Roles for TNF and IL4.

Authors:  S Bergese; R Pelletier; D Vallera; M Widmer; C Orosz
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

10.  Controlled progressive innate immune stimulation regimen prevents the induction of sickness behavior in the open field test.

Authors:  Qun Chen; Andrew J Tarr; Xiaoyu Liu; Yufen Wang; Nathaniel S Reed; Cameron P Demarsh; John F Sheridan; Ning Quan
Journal:  J Inflamm Res       Date:  2013-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.